You searched for "water"
African-Caribbean ethnicity key risk factor for sight-threatening diabetic eye disease
People of African-Caribbean ethnicity with Type 2 diabetes are a third more likely to develop a condition called sight-threatening diabetic retinopathy (STDR) than other ethnic groups, according to researchers from King’s College London. The study, published in the journal Diabetes...Update on emerging therapies for age-related macular degeneration
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...The eye surgeon and eye physician together: the joint ophthalmic clinic
Since the early 19th century, physicians and surgeons have been working together in eye clinics and hospitals to bring about the best outcome for the patients. From the early Babylonian age, important advances in ophthalmic knowledge arose in a stuttered...
Metamorphopsia in idiopathic epiretinal membranes
The Amsler grid is commonly used for self-monitoring, but is qualitative and has low sensitivity. The M-chart reduces the amount of spatial redundancy (‘filling in’) in the Amsler grid. The Orientation Discrimination (OD) test studied in this paper consists of...£1 million boost for wireless innovations to improve patient care
Trials of new wireless technologies to help improve patient care and strengthen connectivity in A&Es and ambulance bays are set to launch across seven NHS trusts, following new funding from NHS England.Corza Medical climbs Snowdon to support Orbis UK
On Saturday 17th June a team of Corza Medical employees from their Solihull HQ are going to be climbing Mount Snowdon, the highest peak in Snowdonia (Wales).Treatment for cause of sudden sight loss now available through the NHS in England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...NICE approves treatment for cause of sudden sight loss
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...
